320 related articles for article (PubMed ID: 19930184)
1. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Seif AE; Grupp SA
Br J Haematol; 2010 Jan; 148(2):205-16. PubMed ID: 19930184
[TBL] [Abstract][Full Text] [Related]
2. Advances in autoimmune lymphoproliferative syndromes.
Madkaikar M; Mhatre S; Gupta M; Ghosh K
Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
[TBL] [Abstract][Full Text] [Related]
3. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
Li P; Huang P; Yang Y; Hao M; Peng H; Li F
Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
[TBL] [Abstract][Full Text] [Related]
4. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
Teachey DT
Curr Opin Pediatr; 2012 Feb; 24(1):1-8. PubMed ID: 22157362
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shah S; Wu E; Rao VK; Tarrant TK
Curr Allergy Asthma Rep; 2014 Sep; 14(9):462. PubMed ID: 25086580
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
[TBL] [Abstract][Full Text] [Related]
7. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
Failing C; Blase JR; Walkovich K
Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.
Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M
Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic dilemma: ALPS versus Evans syndrome.
Li E; Grimes AB; Rider NL; Mahoney DH; Fleisher TA; Shearer WT
Clin Immunol; 2017 Oct; 183():247-248. PubMed ID: 28802957
[No Abstract] [Full Text] [Related]
10. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
[TBL] [Abstract][Full Text] [Related]
11. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
[TBL] [Abstract][Full Text] [Related]
13. How I treat autoimmune lymphoproliferative syndrome.
Rao VK; Oliveira JB
Blood; 2011 Nov; 118(22):5741-51. PubMed ID: 21885601
[TBL] [Abstract][Full Text] [Related]
14. Next Generation Sequencing for Detecting Somatic
López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
Front Immunol; 2021; 12():656356. PubMed ID: 33995372
[TBL] [Abstract][Full Text] [Related]
15. [Primary immunodeficiencies presenting with autoimmune cytopenias in adults].
Sève P; Broussolle C; Pavic M
Rev Med Interne; 2013 Mar; 34(3):148-53. PubMed ID: 22703729
[TBL] [Abstract][Full Text] [Related]
16. RASGRP1 mutation in autoimmune lymphoproliferative syndrome-like disease.
Mao H; Yang W; Latour S; Yang J; Winter S; Zheng J; Ni K; Lv M; Liu C; Huang H; Chan KW; Pui-Wah Lee P; Tu W; Fischer A; Lau YL
J Allergy Clin Immunol; 2018 Aug; 142(2):595-604.e16. PubMed ID: 29155103
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune Lymphoproliferative Syndrome with Red Cell Aplasia.
Meena KR; Bisht S; Tamaria KC
Indian J Pediatr; 2015 Dec; 82(12):1172-4. PubMed ID: 25972287
[TBL] [Abstract][Full Text] [Related]
18. [Autoimmune lymphoproliferative syndrome. Update and review].
Suárez-Gutiérrez M; Yamazaki-Nakashimada MA; Espinosa S; Blancas-Galicia L; Lugo-Reyes SO; Álvarez-Cardona A
Rev Alerg Mex; 2019; 66(4):456-473. PubMed ID: 32105427
[TBL] [Abstract][Full Text] [Related]
19. Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS).
Yokoyama S; Perera PY; Terawaki S; Watanabe N; Kaminuma O; Waldmann TA; Hiroi T; Perera LP
J Clin Immunol; 2015 Oct; 35(7):661-7. PubMed ID: 26453583
[TBL] [Abstract][Full Text] [Related]
20. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
Front Immunol; 2021; 12():671755. PubMed ID: 34447369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]